CBPE Sells Rosemont to Perrigo

London, Uk-based CBPE Capital has sold Rosemont Pharmaceuticals to Perrigo Company, the $10 billion US listed pharmaceuticals business. CBPE acquired Rosemont in August 2006. The sale to Perrigo represents an investment multiple of 3.25x.

DealsNorth AmericaUSBriefs